Skip to main content
letter
. 2013 Jun 5;30(2):211–213. doi: 10.4274/Tjh.2012.0013

Table 1. Characteristics of CML patients with F317L mutation with MMR under dasatinib published in the literature.

graphic file with name TJH-30-211-g1.jpg